Cavidi
Uppsala
About Cavidi
Cavidi is Sweden’s leading supplier of viral load for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s diagnostics reduce the cost of treatment and the spread of HIV. Cavidi also provides tools and kits for virus research to many of the world’s leading labs. Cavidi is a Swedish biotech company founded as a spin-off from Uppsala University. Their expertise is based on understanding viruses and using this knowledge to create research tools and clinical diagnostics. Today their focus is on HIV but our methods and expertise can be applied to other viruses. Cavidi’s head office is in Uppsala, Sweden and they have sales offices in South Africa, India and USA. Their customers include hospitals, patient clinics, private laboratories, the pharmaceutical industry and research institutions worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.5M
- Last round: Series Unknown (Feb 2018)
- Website: cavidi.se
- Phone: 46 18 55 20 40
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cavidi-59278 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.